VHCP Management as of June 30, 2013
Portfolio Holdings for VHCP Management
VHCP Management holds 17 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 19.5 | $26M | 2.0M | 13.38 | |
| Ironwood Pharmaceuticals (IRWD) | 13.3 | $18M | 1.8M | 9.93 | |
| Keryx Biopharmaceuticals | 11.4 | $15M | 2.0M | 7.47 | |
| Dyax | 10.7 | $14M | 4.2M | 3.46 | |
| Anacor Pharmaceuticals In | 6.7 | $9.0M | 1.6M | 5.59 | |
| Tesaro | 6.3 | $8.5M | 261k | 32.74 | |
| Gw Pharmaceuticals Plc ads | 5.5 | $7.4M | 838k | 8.81 | |
| Vanda Pharmaceuticals (VNDA) | 4.7 | $6.4M | 788k | 8.08 | |
| Biodel | 4.5 | $6.0M | 1.4M | 4.18 | |
| Chelsea Therapeutics International | 4.3 | $5.8M | 2.5M | 2.30 | |
| Hyperion Therapeutics | 4.2 | $5.6M | 255k | 22.00 | |
| Threshold Pharmaceuticals | 2.7 | $3.6M | 684k | 5.26 | |
| GTx | 2.5 | $3.3M | 500k | 6.60 | |
| Alexza Pharmaceuticals | 1.3 | $1.7M | 400k | 4.34 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $1.6M | 1.0M | 1.55 | |
| D Stemline Therapeutics | 0.9 | $1.2M | 50k | 23.84 | |
| Anthera Pharmaceuticals | 0.5 | $661k | 1.4M | 0.46 |
